We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
94 hedge funds and large institutions have $141M invested in Cardiff Oncology in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
12% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $2.58M
4% more funds holding
Funds holding: 90 → 94 (+4)
17.24% less ownership
Funds ownership: 70.64% → 53.41% (-17%)
20% less capital invested
Capital invested by funds: $176M → $141M (-$35.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
30
Reduced
26
Closed
15
Calls
$2.88M
Puts
$2.58M
Net Calls
+$301K
Net Calls Change
+$540K
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$2.4M |
| 2 |
Goldman Sachs
New York
|
+$1.73M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$1.32M |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$1.12M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
